MCRC Blog
MCRC Blog
29/01/2024
We’re recruiting Science Communication Ambassadors
Are you a Cancer Sciences PhD student looking to gain experience of science communication? We’re looking to recruit up to three Science Communication Ambassadors to develop digital and social media content to communicate scientific research and help us engage with prospective PhD students.
MCRC Blog
03/01/2024
Congratulations to our students on passing their PhD vivas
We are thrilled to extend our congratulations to students from the Manchester Cancer Research Centre and Cancer Research UK Manchester Centre who have recently passed their PhD vivas.
MCRC Blog
07/12/2023
MCRC Annual Report 2022/2023 Available Now
The year's major achievements include opening our flagship new research building, milestones in clinical research and international partnerships.
MCRC Blog
24/10/2023
Starting in Science Day 2023
MCRC Blog
30/08/2023
‘Together in Research’ Building Trust About Research in Our Community
On 26th July, the MCRC welcomed representatives of the charity Can Survive UK with the aim of co-creating research projects directly with the community.
MCRC Blog
30/06/2023
ESTRO 2023
MCRC Blog
19/06/2023
How to commercialise your research
University of Manchester Innovation Factory Ltd is the University’s agent for commercialisation and drives technology transfer for the University. Their mission is to use the Intellectual Property (IP) developed at The University of Manchester to create positive social, economic and environmental impact. Read more about how to commercialise your research in this blog.
MCRC Blog
08/06/2023
You only need lungs to get lung cancer
MCRC Blog
15/05/2023
The Christie Paterson cancer research centre completes
Following a devastating fire which caused significant damage to the Paterson cancer research facility in 2017, building work on the new Paterson building at The Christie NHS Foundation Trust in Manchester has completed.
MCRC Blog
23/03/2023
Wisdom from The West
MCRC Blog
09/02/2023
Developing treatment options for high-grade serous ovarian cancer (HGSOC)
We talk to Dr Anya Golder who completed her PhD on HGSOC. She details her research into new therapies and the multiple-low-dose approach.
MCRC Blog
04/02/2023